After treatment with Lenvatinib, the positive expression rate of Ki-67 and PCNA in RBE+M2 group was significantly higher than that in RBE group, which may be related to the role of M2 in promoting tumor cell proliferation. This evidence concerns the gene MKI67 and neoplasm.